Yael Wexler-cohen

Title: The Innovative Contributions of Yael Wexler-Cohen

Introduction

Yael Wexler-Cohen is a prominent inventor based in Thousand Oaks, California. She has made significant contributions to the field of biotechnology, particularly in the development of protein formulations. Her work has the potential to impact various medical applications, especially in ophthalmology.

Latest Patents

Yael holds a patent for VEGFR-Fc fusion protein formulations. This patent encompasses protein formulations and methods of making and using such formulations. The formulation can be utilized as an ophthalmic solution, specifically for intravitreal administration. In some embodiments, the formulation includes a VEGFR-Fc fusion protein, such as aflibercept.

Career Highlights

Yael Wexler-Cohen is associated with Amgen Inc., a leading biotechnology company. Her role at Amgen has allowed her to work on groundbreaking research and development projects. With her expertise, she has contributed to advancements in therapeutic solutions that address critical health issues.

Collaborations

Throughout her career, Yael has collaborated with notable colleagues, including William Callahan and Robert Matthew Fesinmeyer. These collaborations have fostered an environment of innovation and have led to the successful development of new technologies.

Conclusion

Yael Wexler-Cohen's contributions to the field of biotechnology, particularly through her patent on VEGFR-Fc fusion protein formulations, highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments.